Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.03
-0.28 (-0.96%)
May 17, 2024, 4:00 PM EDT - Market closed
HRMY Employees
Harmony Biosciences Holdings had 246 employees on December 31, 2023. The number of employees increased by 46 or 23.00% compared to the previous year.
Employees
246
Change (1Y)
46
Growth (1Y)
23.00%
Revenue / Employee
$2,510,207
Profits / Employee
$559,764
Market Cap
1.65B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 246 | 46 | 23.00% |
Dec 31, 2022 | 200 | 20 | 11.11% |
Dec 31, 2021 | 180 | 30 | 20.00% |
Dec 31, 2020 | 150 | 0 | - |
Dec 31, 2019 | 150 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Tilray Brands | 1,600 |
Taro Pharmaceutical Industries | 1,554 |
Schrödinger | 867 |
Supernus Pharmaceuticals | 652 |
InMode | 581 |
Kura Oncology | 142 |
Structure Therapeutics | 93 |
HRMY News
- 18 days ago - Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy - GlobeNewsWire
- 18 days ago - Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets - PRNewsWire
- 4 weeks ago - HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 - PRNewsWire
- 5 weeks ago - HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST - PRNewsWire
- 6 weeks ago - HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME - PRNewsWire
- 7 weeks ago - HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE - PRNewsWire
- 2 months ago - HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - PRNewsWire
- 3 months ago - Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates - GlobeNewsWire